📄 Cross-examination of Dr. Fredric Rieders (part 1) — Monday, August 14, 1995
Address:
C:\DEPT103\CRIMINAL\1995\AUG\14\CROSS-EXAMINATION-OF-DR-FREDRI.DOC
TRIAL
▲ Day 135 of 167

Cross-examination of Dr. Fredric Rieders (part 1)

Witness: Dr. Fredric Rieders
Examiner: Marcia Clark
Called by: Defense • Date: Monday, August 14, 1995 • Utterances: 258
Marcia Clark resumes cross-examination of defense toxicology expert Dr. Fredric Rieders, focusing entirely on his role in the 1988 Sconce oleander poisoning case to undermine his credibility. Clark methodically attacks inconsistencies in Rieders' work: his formal report omitted the finding of oleandrigenin despite him calling it an important corroborative factor; his lab notes are missing from the file he brought to court; and a defense toxicologist named Dr. Finkle allegedly recalls Rieders telling him he only found one compound. The session ends with Clark attempting to introduce a memo from prosecutor Kevin Denoce that appears to contradict Rieders' claim that no one asked him to reconcile his positive results with a later negative test by Dr. Henion.
1 (The following proceedings were held in open court, in the presence of the jury:)
2 THE COURT:

Thank you, ladies and gentlemen. Please be seated. All right. Let the record reflect that we have been rejoined by all the members of our jury. Good morning, ladies and gentlemen.

THE JURY: Good morning.

3 THE COURT:

My apologies to you for the late start this morning; however, I've been meeting with the lawyers in chambers to discuss some issues that may be coming up that I have to deal with and to advise you that there may be some other delays later this week, as I have some other issues I need to deal with. All right. We have Dr. Fredric Rieders back with us. Good morning, Dr. Rieders.

4 DR. RIEDERS:

Good morning, your Honor.

5 THE COURT:

All right. Would you take the witness stand, please.

Fredric Rieders, called on behalf of the Defendant, having been previously sworn, resumed the stand and testified further as follows:

6 THE COURT:

All right. The record should reflect that Dr. Fredric Rieders is again on the witness stand. And ladies and gentlemen, if you recollect, on July the 24th Dr. Rieders presented his direct testimony under questioning by Mr. Blasier and on July the 25th we started the cross-examination by Miss Clark. And because of Dr. Rieders' other commitments, we had to interrupt his cross-examination, completion of his testimony, and we are going to conclude his testimony this morning. Having said that, good morning, Dr. Rieders.

7 DR. RIEDERS:

Good morning, your Honor.

8 THE COURT:

Doctor, you are reminded, sir, you are still under oath. And Miss Clark, you may continue with your cross-examination.

9 MS. CLARK:

Thank you, your Honor. Good morning, ladies and gentlemen.

THE JURY: Good morning.

CROSS-EXAMINATION (RESUMED) BY MS. CLARK

10 MS. CLARK:

Good morning, Dr. Rieders. When we left off with your testimony on July 24th, sir, we were talking about the Sconce case, a case in which the victim was--they were attempting to determine whether or not the victim died of natural causes or of oleander poisoning. Do you recall when we were discussing that, sir?

11 DR. RIEDERS:

I wasn't trying to determine whether he died of natural causes. I was trying to determine if--

12 MS. CLARK:

Sir, would you please listen to my question. Objection, motion to strike as nonresponsive.

13 THE COURT:

All right. Stricken. The jury is do disregard. Ask the question again.

14 MS. CLARK:

Do you recall that we were discussing that topic when you last testified on July 24th, sir?

15 DR. RIEDERS:

That is not the way I recall it.

16 MR. BLASIER:

Objection, that misstates the prior testimony.

17 THE COURT:

All right. He has indicated that is not how he recalls it. Next question.

18 MS. CLARK:

Do you recall that you were asked to test some tissues as to whether or not--whether or not the victim died of oleander poisoning in the case of People versus Sconce back in 1988?

19 DR. RIEDERS:

That is not the way I recall it.

20 MS. CLARK:

What do you recall?

21 DR. RIEDERS:

I recall that Dr. Basil asked me to corroborate on the gate analysis which he had done for the Coroner to determine whether or not oleander constituents were present in tissues.

22 MS. CLARK:

And what was the point of doing that?

23 DR. RIEDERS:

For the authorities to decide whether or not this was a natural death or not.

24 MS. CLARK:

All right. And that is precisely--

25 DR. RIEDERS:

Or to help them to decide.

26 MS. CLARK:

All right. And the reason that you were asked to do, that, sir, is to provide scientific evidence that would indicate whether or not the victim had died of oleander poisoning or of natural causes; isn't that true?

27 DR. RIEDERS:

That was the apparent intention of the attorneys--the area, yes.

28 MS. CLARK:

And so you did perform those tests on tissues back in 1988, correct?

29 DR. RIEDERS:

I performed the analysis in 1988; that's correct.

30 MS. CLARK:

And you performed the analysis on tissues that were recovered from the 1985 autopsy, correct?

31 DR. RIEDERS:

That had been in the freezer since 1985, right.

32 MS. CLARK:

Is it your testimony, sir, that it had been in a freezer since the time that those tissues were taken at autopsy this 1985?

33 DR. RIEDERS:

That is what Dr. Lovell told me, yes.

34 MS. CLARK:

Sir, do you recall performing some of your testing on the fixing fluid known as formalin?

35 DR. RIEDERS:

Yes.

36 MS. CLARK:

And that fixing fluid is used to preserve tissues that are refrigerated and not frozen; isn't that correct?

37 DR. RIEDERS:

That fluid is used on tissues which may not even be refrigerated, which are kept in a glass jar in storage for making sections, but the tissues that Dr. Lovell sent me, or rather, that Dr. Basil sent me, because I got them from Dr. Basil, according to him and Dr. Lovell, had been kept frozen.

38 MS. CLARK:

They were kept frozen in the fixing solution called formalin?

39 DR. RIEDERS:

No.

40 MS. CLARK:

Then why were you testing formalin for the presence of oleandrin?

41 DR. RIEDERS:

I think that that was in addition to tissues. I don't remember why, but the formalin that I received evidently had been in contact with the tissues because it turned--I believe it turned out to have oleandrin in it. I'm not sure about that. It is one of the pieces that goes with the case. That is all I recall--can tell.

42 MS. CLARK:

What would be the purpose of having formalin? Why would you have formalin if the tissues were frozen?

43 MR. BLASIER:

Your Honor, I'm going to object on 352 grounds.

44 THE COURT:

Overruled.

45 DR. RIEDERS:

Because the formalin would reflect the environment of tissues that are kept in formalin, I assume, or else the formalin was material used for embalming the body, I don't recall. Either one happens all the time, that with old cases one gets a sample of formalin, either from tissues--from wet tissues as they call it, or from the embalming fluid.

46 MS. CLARK:

Is it your testimony, sir, that they put tissues taken from a victim at autopsy into formalin and freeze it in the formalin?

47 DR. RIEDERS:

No. I didn't say that.

48 MS. CLARK:

All right. So if you had formalin fluid that you--

49 DR. RIEDERS:

Excuse me. I made it very clear before that the tissues that are put in formalin are usually kept on a shelf, not even refrigerated.

50 MS. CLARK:

Then the fact that you tested formalin fluid from the tissues taken from the victim in the Sconce case would indicate that they were not frozen right away, wouldn't it?

51 DR. RIEDERS:

It doesn't indicate anything except that I got some formalin which could have been embalming fluid or it could have been formalin in which tissues were fixed.

52 MS. CLARK:

Nevertheless, you did test the tissues and the formalin that was recovered from the 1985 autopsy, correct?

53 DR. RIEDERS:

I would have to refresh my memory.

54 (Brief pause.)
55 MS. CLARK:

Exactly what is it that you are trying to refresh your memory about at this time, sir?

56 DR. RIEDERS:

Whether or not I tested formalin.

57 MS. CLARK:

And the file that you are looking through, sir, is that your pile from the Sconce case?

58 DR. RIEDERS:

Yes. What is lit of it anyway.

59 MS. CLARK:

You don't have the entire file there?

60 DR. RIEDERS:

Not here.

61 MS. CLARK:

Why do you not have the entire file?

62 DR. RIEDERS:

The entire file or the rest of all kind of extraneous things are in the hands of Mr. Blasier.

63 MS. CLARK:

Mr. Blasier?

64 DR. RIEDERS:

Yes.

65 MS. CLARK:

And when did you give Mr. Blasier this file, sir?

66 MR. BLASIER:

Objection, irrelevant.

67 THE COURT:

Sustained.

68 MS. CLARK:

Your Honor, I would like to--

69 THE COURT:

This is far afield about formalin and whether or not it was tested.

70 MS. CLARK:

I will withdraw the question, Dr. Rieders, about formalin.

71 THE COURT:

All right.

72 DR. RIEDERS:

Yes.

73 THE COURT:

Next question.

74 DR. RIEDERS:

I analyzed it as fixing fluid. That is what it was labeled.

75 MS. CLARK:

Okay. And that is formalin, isn't it, sir, fixing fluid?

76 DR. RIEDERS:

In this case, yes. There are other fixing fluids.

77 MS. CLARK:

So you did analyze that in this case?

78 DR. RIEDERS:

Yes.

79 MS. CLARK:

And that would tend to indicate to you--never mind. Strike that. When you got the tissues, sir, were they frozen?

80 DR. RIEDERS:

Yes. I got the tissues. I got homogenates and blood as they were frozen. They were shipped to me frozen by Dr. Basil.

81 MS. CLARK:

You maintained them in a frozen condition, didn't you?

82 DR. RIEDERS:

Yes, except for sampling.

83 MS. CLARK:

And you performed three tests, correct, the radioimmunoassay fluorescent spectrometry and thin layer chromatography, correct?

84 DR. RIEDERS:

Fluorescent spectrophotometry, yes, and high performance thin layer chromatography which is a little different.

85 THE COURT:

All right. Dr. Rieders--

86 MS. CLARK:

Now, those tests--

87 THE COURT:

Why don't you swing the microphone--

88 DR. RIEDERS:

I'm sorry.

89 MS. CLARK:

Now, those tests were the state of the art back in the sixties, weren't they?

90 THE COURT:

Sixties?

91 MS. CLARK:

Yeah, sixties.

92 MR. BLASIER:

Objection, vague as to the terminology.

93 THE COURT:

Overruled. What is the relevance of the sixties? These tests were done in the late eighties.

94 MS. CLARK:

I know, your Honor.

95 THE COURT:

Proceed. No, proceed.

96 MS. CLARK:

That is the point.

97 THE COURT:

Proceed.

98 DR. RIEDERS:

Actually in the sixties--

99 THE COURT:

Wait, wait, wait.

100 DR. RIEDERS:

I'm sorry.

101 THE COURT:

Proceed.

102 MS. CLARK:

Do you recall--when you began practicing as a toxicologist, that was in the fifties; is that correct, sir?

103 DR. RIEDERS:

In the forties.

104 MS. CLARK:

In the forties, and in the sixties what was the state of the art testing?

105 MR. BLASIER:

Objection, irrelevant.

106 THE COURT:

Sustained.

107 MS. CLARK:

All right. When you performed those tests, the result you got was positive for the presence of oleandrin, correct?

108 DR. RIEDERS:

Yes, and oleandrigenin.

109 MS. CLARK:

Oleandrigenin. The premise of oleandrigenin is an important fact, is it not, sir?

110 DR. RIEDERS:

In the identification, yes.

111 MS. CLARK:

And that is important because when you have decayed or decomposed tissue, the substance oleandrin may break down into a metabolite, in this case oleandrigenin, so even though you don't have oleandrin, if you have oleandrigenin, you can still substantiate that it is present; isn't that right?

112 DR. RIEDERS:

No, ma'am, that is not right, if I may correct you.

113 MS. CLARK:

If it is not, sir, then let me ask you another question.

114 DR. RIEDERS:

Well, let me explain, if I may.

115 MR. BLASIER:

Objection.

116 THE COURT:

Hold on. He can answer the question. Answer the question, doctor. Go ahead.

117 DR. RIEDERS:

I said no, that is incorrect. May I explain what is correct? Oleandrigenin is formed in the body as well when you take it--when you take oleandrin into the body. It is also formed in the plant itself, in the oleander plant itself. It also is formed if oleander--oleandrin starts to break down for any other reason. So in this particular case the issue was not whether this was a decomposed tissue, but whether or not there were compounds present which would give a pattern, which is more important than just a single compound that is consistent with and therefore corroborative of having originated in oleander, the constituents. That is what the oleandrigenin means in this case, that on the thin layer chromatography that plus some other metabolites or breakdown products of oleandrin, were found, giving a pattern which gives a high degree of identifiability to the compound because you have a whole pattern rather than just one little streak.

118 THE COURT:

Next question.

119 MS. CLARK:

So then the finding of oleandrigenin was an important corroborative tool for you to determine that in fact that it was oleandrin that you saw?

120 MR. BLASIER:

Objection, argumentative, 352.

121 THE COURT:

Overruled.

122 DR. RIEDERS:

It was one of them, yes, of course.

123 MS. CLARK:

Do you have the report that you submitted on the case concerning your findings?

124 DR. RIEDERS:

All I have is the handwritten report. I don't have any of the typed copies, or a copy of the handwritten report I should say.

125 MS. CLARK:

All right. Doctor, I'm going to show you a copy of the report--the typed report that you did back in the Sconce case. I will give a copy to counsel.

126 (Brief pause.)
127 MS. CLARK:

I'm going to show you a copy as well, doctor, and I'm going to ask you to point out where in this report that you determine that you found oleandrigenin?

128 DR. RIEDERS:

It is not in the report, but it is in my notes.

129 MS. CLARK:

It is not in the formal report, doctor?

130 DR. RIEDERS:

No, it isn't.

131 MR. BLASIER:

Objection, argumentative.

132 THE COURT:

Sustained. Rephrase the question.

133 MS. CLARK:

You acknowledge that is an important finding, the oleandrigenin, yet you did not put that into the report?

134 DR. RIEDERS:

It wasn't important to the report. It was important to my conclusion of the report to have enough factors to call this with reasonable certainty, the presence of oleander.

KEY QUOTE
135 MS. CLARK:

And let me ask you then, doctor, why was it not important to put in a report when you just acknowledged that the constituents of oleandrin were an important corroborative tool?

136 MR. BLASIER:

Objection, argumentative.

137 THE COURT:

Sustained. Rephrase the question.

138 MS. CLARK:

Did you not put that into your report to Dr. Lovell?

139 MR. BLASIER:

Objection, asked and answered.

140 THE COURT:

Overruled.

141 (No audible response.)
142 MS. CLARK:

Is that right?

143 DR. RIEDERS:

That is what right.

144 MS. CLARK:

It did not include the finding of oleandrigenin in your report to Dr. Lovell; is that correct, sir?

145 DR. RIEDERS:

Hold on.

146 (Brief pause.)
147 DR. RIEDERS:

That is correct.

148 MS. CLARK:

Now, don't you--now, Dr. Lovell, he was the Coroner back then; is that correct?

149 DR. RIEDERS:

That's correct; pathologist.

150 MS. CLARK:

Pathologist. And he had signed off on the report back in 1985 in which his medical examiner, Dr. Holloway, determined that the victim died of natural causes actually from a fatty liver--liver disease, correct?

151 DR. RIEDERS:

I don't have any of that information.

152 MR. BLASIER:

Objection, no foundation.

153 THE COURT:

He has indicated he has no information.

154 MS. CLARK:

Doctor, did you read the autopsy report created by Dr. Holloway back in 1985?

155 DR. RIEDERS:

I don't recall and I don't have a copy of it.

156 MS. CLARK:

You don't recall? You remember testifying in the Sconce preliminary hearing, do you not?

157 DR. RIEDERS:

Yes, I remember testifying.

158 MS. CLARK:

And do you recall testifying that you had in fact read that autopsy report?

159 DR. RIEDERS:

I don't recall it, but if a transcript says so, then I did. I'm telling you I don't recall.

160 MS. CLARK:

Would it refresh your memory, sir, if I were to show you a page from that preliminary hearing?

161 DR. RIEDERS:

Possibly.

162 MS. CLARK:

In which you acknowledged that you read the autopsy report?

163 DR. RIEDERS:

Well, I don't--you know, I don't deny that I read it. I don't recall that I read it and I don't have a copy now of the autopsy report. That is all I told you.

164 MS. CLARK:

Well, then let me show you a copy of the autopsy report, sir.

165 MR. BLASIER:

Objection, 352.

166 THE COURT:

Sustained. It is irrelevant.

167 MS. CLARK:

May I be heard, your Honor?

168 THE COURT:

No.

169 MS. CLARK:

Were you aware, at the time that you did your testing, sir, that there had already been an autopsy report prepared in which it was written that the victim died of natural causes?

170 MR. BLASIER:

Objection, no foundation, irrelevant.

171 THE COURT:

Sustained.

172 MS. CLARK:

Sir, were you--did you--when you testified at the preliminary hearing you recall testifying that there had been an initial determination that the victim died of natural causes based on the autopsy report, correct?

173 (No audible response.)
174 THE COURT:

Counsel, I don't know what the relevance is of this because we've already established the reason he was doing this testing was to determine whether or not this person died as a result of oleander poisoning, not natural causes, so the jury already knows that. That was the purpose of this testing, so let's move on.

175 MS. CLARK:

This goes to the nature of the report, your Honor.

176 THE COURT:

The report is not real relevant.

177 MS. CLARK:

All right. Dr. Rieders, nevertheless, you acknowledge you did not write the finding of oleandrigenin into your report?

178 MR. BLASIER:

Objection, asked and answered.

179 THE COURT:

Sustained.

180 MS. CLARK:

You did put it in your notes, is that what your testimony is?

181 DR. RIEDERS:

It was a part of the observation, an important part of it, just like in the paper that we wrote.

182 MS. CLARK:

Can you show me the notes that you are referring to?

183 DR. RIEDERS:

Well, maybe.

184 (Brief pause.)
185 DR. RIEDERS:

I don't know whether I still have them.

186 (Brief pause.)
187 DR. RIEDERS:

No, it is not in here the rad sheet and the thin layer results or the thin layer laboratory notes are not in here. None of the lab notes are in here.

KEY QUOTE
188 THE COURT:

All right. Doctor, why don't you swing the microphone back.

189 MS. CLARK:

So you have nothing in the notes now before you that indicate that you found oleandrigenin?

190 DR. RIEDERS:

That is what I said, yes.

191 MS. CLARK:

And in your testimony at the Sconce preliminary hearing--

192 DR. RIEDERS:

I have nothing in my notes of the actual description of the thin layer.

193 MS. CLARK:

You recall testifying at the preliminary hearing in the Sconce case, sir? You never mentioned the finding of oleandrigenin, do you recall?

194 DR. RIEDERS:

I don't recall. I may not have.

195 MS. CLARK:

And if we take time over the break and I let you review the testimony that you have in the Sconce matter, you can refresh your memory as to whether or not you did in fact testify to that finding?

196 MR. BLASIER:

Your Honor, I'm going to object and ask to approach.

197 THE COURT:

Sustained. No. Sustained. It is irrelevant.

198 MS. CLARK:

Okay. Dr. Rieders, do you recall having a conversation with a man by the name of Dr. Brian Finkle in Anaheim back in 1990?

199 DR. RIEDERS:

Yes, yes.

200 MS. CLARK:

And that man was a toxicologist for the Defense in the Sconce case; is that correct?

201 DR. RIEDERS:

Yes.

202 MS. CLARK:

And you recall telling him that you found one spot on your thin layer chromatography which would indicate that you only found oleandrin and not oleandrigenin?

203 DR. RIEDERS:

Absolutely not. I have a rather clear recollection of my conversation with Brian. That is not what I told him.

204 MS. CLARK:

So if he came and told us that, sir, that would be incorrect? Is that your testimony?

205 MR. BLASIER:

Objection, improper question. Argumentative.

206 THE COURT:

Overruled.

207 DR. RIEDERS:

If that is what he told you, he is mistaken or else--

KEY QUOTE
208 MS. CLARK:

All right. Now, you turned in your report indicating the finding of oleandrin, correct?

209 DR. RIEDERS:

The qualitative finding of oleandrin, yes.

210 MS. CLARK:

And after that you testified at a preliminary hearing in October of 1990 concerning your finding and that was a--concerning your finding of oleandrin in the body of the victim, correct?

211 DR. RIEDERS:

That's correct.

212 MS. CLARK:

And shortly after that the Defense and the Prosecution agreed to do retesting. Do you recall that?

213 DR. RIEDERS:

I don't know how shortly afterward, but it was afterwards, yes.

214 MS. CLARK:

Well, you testified in October of 1990 the Defendant was held to answer and the testing began in the beginning of 1991. Does that sound about right to you?

215 DR. RIEDERS:

I thought it came in April of 1991 because when we met in I think Anaheim and Brian Finkle and I went over what I still had left, they hadn't done the testing yet. They hadn't contacted the testing people.

216 MS. CLARK:

Before they did the testing, though, the body of the victim was exhumed, correct?

217 DR. RIEDERS:

It wasn't exhumed. It was lying exposed in the mausoleum so it was pulled out of the mausoleum and reautopsied, what was left of it, by Dr. Lovell and a Dr. Root.

218 MS. CLARK:

Right.

219 DR. RIEDERS:

And at that time specimens were taken from that cadaver and those are the specimens that were then forwarded to--for testing.

220 MS. CLARK:

Now, Dr. Rieders, you were aware of that exhumation--well for lack of a better term, exhumation, but you were not present, correct?

221 DR. RIEDERS:

At the time I wasn't aware of it. I certainly wasn't present.

222 MS. CLARK:

You were or were not aware of it?

223 DR. RIEDERS:

I was not, not at the time.

224 MS. CLARK:

Okay. When did you become aware of the exhumation?

225 DR. RIEDERS:

When Dr. Lovell called me and told me that he had done an exhumation with Dr. Root and that they had taken specimens and the half that Dr. Root had was going to Brian--to Jack Henion at Cornell and the other half he was going to send to me for safekeeping.

226 MS. CLARK:

Sent exhumation tissues to you?

227 DR. RIEDERS:

For safekeeping, yes.

228 MS. CLARK:

And why would he send exhumation tissues to you, Dr. Rieders?

229 DR. RIEDERS:

Ask him.

230 MS. CLARK:

All right. Were you planning to do testing on it?

231 DR. RIEDERS:

No.

232 MS. CLARK:

So you were just supposed to keep them, hold them?

233 DR. RIEDERS:

Well, that is what he asked me to do.

234 MS. CLARK:

Can you think of any reason why Dr. Lovell would not keep those himself at the morgue?

235 MR. BLASIER:

Objection, calls for speculation, irrelevant.

236 THE COURT:

Sustained.

237 MS. CLARK:

All right. Now, shortly after that exhumation, sir, were you informed by the D.A. that the testing performed by Dr. Henion for the presence of oleandrin turned up negative?

238 DR. RIEDERS:

Harvey Giss, yes, notified me.

239 MS. CLARK:

All right. Do you recall also talking to a Prosecutor by the name of Kevin Denoce?

240 DR. RIEDERS:

I don't recall. The only thing I recall about Denoce is two things: One, that he--I was supposed to contact him prior to trial, but to wait. The other thing I recall is that he sent through Harvey Giss a paper to me which he asked me to review whether or not that could be a basis for questioning the results and that was a paper that dealt with a substance that is called national natrutic, N-A-T-R-U-T-I-C, hormone, which tends to cross-react with digitalis and probably oleandrin in the radioimmunoassay test. That is the only thing I recall about Denoce. That is the question only that he raised.

241 MS. CLARK:

You don't recall discussing with Denoce--with Mr. Denoce the reason--well, let me strike that. You don't recall Denoce calling you to ask you to give him a scientifically acceptable reason that would reconcile your positive results with Dr. Henion's negative results?

242 DR. RIEDERS:

Absolutely not. Nobody asked me to reconcile anything.

KEY QUOTE
243 MS. CLARK:

No one ask you to reconcile anything?

244 DR. RIEDERS:

Nobody talked to me, for practical purposes, after that, as far as I recall.

245 MS. CLARK:

Sir, I have a memo here from Denoce that I would like to show you.

246 MR. BLASIER:

Objection.

247 THE COURT:

Show it to Mr. Blasier.

248 MS. CLARK:

Uh-huh. Let me direct counsel to page 6, the bottom of page 6, going up through all the page 7.

249 (Brief pause.)
250 THE COURT:

This is a memo from Mr. Denoce to Dr. Rieders?

251 MS. CLARK:

Yes, your Honor. I would ask that it be marked next in order--no, this is to his boss, Michael Bradbury.

252 MR. BLASIER:

I object and ask to approach.

253 THE COURT:

Wait. It is a memo from Denoce to Bradbury?

254 MS. CLARK:

Right. It is a memo from Kevin Denoce to Michael Bradbury and Harvey Giss in which--

255 THE COURT:

Okay.

256 MS. CLARK:

People's next in order.

257 MR. BLASIER:

I object and ask to approach.

258 THE COURT:

All right. With the court reporter.

Temperature

tense

Key Quotes (4)

Dr. Fredric Rieders
It wasn't important to the report. It was important to my conclusion of the report to have enough factors to call this with reasonable certainty, the presence of oleander.
Rieders defends omitting a key finding from his formal report — Clark uses this contradiction to suggest sloppiness or selective reporting, directly applicable to his credibility in the OJ EDTA findings.
Dr. Fredric Rieders
Absolutely not. Nobody asked me to reconcile anything.
Flat denial that prosecutors ever asked him to explain away the conflict between his positive results and Henion's negative results — immediately undercut by Clark producing a memo suggesting otherwise.
Dr. Fredric Rieders
If that is what he told you, he is mistaken or else--
Rieders calls opposing expert Dr. Finkle mistaken about their conversation, setting up a direct factual conflict between two credentialed experts.
Dr. Fredric Rieders
No, it is not in here the rad sheet and the thin layer results or the thin layer laboratory notes are not in here. None of the lab notes are in here.
Rieders is unable to produce the underlying lab notes that would corroborate his claim about finding oleandrigenin — a damaging admission during cross.

Evidence (3)

null
Typed report Rieders submitted in the Sconce case documenting his oleandrin findings
Shown to witness; Clark uses it to establish oleandrigenin was not included in the formal report
People's next in order
Internal memo from prosecutor Kevin Denoce to supervisors Michael Bradbury and Harvey Giss regarding Rieders' reconciliation of conflicting test results
Clark attempts to introduce; Blasier objects and requests sidebar — transcript ends at this point
null
Sconce preliminary hearing transcript (October 1990) containing Rieders' prior testimony
Referenced by Clark to challenge whether Rieders mentioned oleandrigenin; Ito rules the inquiry irrelevant and sustains objection

Notable Exchanges (4)

Marcia ClarkDr. Fredric Rieders
Clark presses Rieders on why oleandrigenin — which he calls an important corroborative finding — does not appear in his formal report. Rieders distinguishes between what was important to his notes versus what he chose to include in the report. Clark then asks for the notes; Rieders searches and discovers they are not in the file he has with him.
strategic
Marcia ClarkDr. Fredric Rieders
Clark asks whether Rieders told Dr. Finkle he found only one spot on his thin layer chromatography (indicating only oleandrin, not oleandrigenin). Rieders flatly denies it and says Finkle is mistaken. Clark's follow-up — 'so if he came and told us that, sir, that would be incorrect?' — is sustained as improper but the damage is done.
heated
Marcia ClarkLance A. Ito
Ito repeatedly cuts off Clark's line of questioning about the Sconce autopsy report and prior hearing transcript, ruling them irrelevant since the jury already knows the purpose of the testing. Clark pushes back ('This goes to the nature of the report') but Ito is dismissive.
procedural
Marcia ClarkDr. Fredric Rieders
Rieders reveals that the remaining portion of his Sconce case file — including lab notes — is in the possession of defense attorney Robert Blasier. Clark begins to press on when Rieders gave Blasier the file; Ito sustains the objection and cuts the line off.
revealing

Light Moments (1)

Lance A. Ito
Ito interjects mid-question with genuine confusion: 'Sixties?' when Clark asks whether the tests Rieders used were 'state of the art back in the sixties.' Clark confirms, 'Yeah, sixties.' Ito: 'What is the relevance of the sixties? These tests were done in the late eighties.' Clark: 'I know, your Honor.' Ito: 'Proceed. No, proceed.' Clark: 'That is the point.'

Credibility Attacks (4)

⚔ Dr. Fredric Rieders
omission from formal report
Clark establishes that Rieders' formal report in the Sconce case did not include the oleandrigenin finding despite Rieders testifying it was an important corroborative element of his conclusion.
⚔ Dr. Fredric Rieders
missing supporting documentation
Rieders cannot produce his underlying lab notes — including radioimmunoassay sheets and thin layer chromatography results — while on the stand, and what remains of his file is held by defense counsel Blasier.
⚔ Dr. Fredric Rieders
prior inconsistent statement (expert contradiction)
Clark confronts Rieders with defense toxicologist Dr. Finkle's account that Rieders told him he found only one spot on his thin layer chromatography — contradicting Rieders' testimony about finding a multi-compound pattern including oleandrigenin.
⚔ Dr. Fredric Rieders
prior inconsistent statement (document)
Clark introduces (or attempts to introduce) the Denoce memo to impeach Rieders' flat denial that prosecutors ever asked him to reconcile his positive results with Henion's negative findings — the transcript ends before the memo is admitted.

Witness Demeanor

(Brief pause.) — Rieders searches his file to refresh memory on formalin testing
(No audible response.) — Rieders silent when asked whether he omitted oleandrigenin from his Lovell report
(Brief pause.) — Rieders searches for lab notes and cannot locate them
Rieders repeatedly interrupts Clark mid-question to correct her framing, drawing a nonresponsive strike early in the session

Objections

18 objections (10 sustained, 4 overruled)
Proceeding 7293 • 258 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 AUG 14, 1995 📄 Cross-examination of Dr. Fredr
AUG 14, 1995 KRT DvH TD